Naplasol Debuts Enhanced Mycoprotein Range Following Mycorena Acquisition
Naplasol, a Belgian-based protein manufacturer under the VEOS group, is launching its newly acquired Promyc mycoprotein line at the Food Ingredients Europe (FIE) event in Frankfurt next month. This marks a milestone for Naplasol following its August acquisition of the Swedish mycoprotein company Mycorena, which had halted the construction of its production facility and entered bankruptcy earlier this year. With the acquisition finalized, Naplasol has taken over the production of …